Evidence map›Paper›PMID 35325034›Full record

ArticleBrain : a journal of neurology2022

Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.

Moe Watanabe, Caroline M Kopruszinski, Aubin Moutal, Daigo Ikegami, Rajesh Khanna, Yanxia Chen, Sarah Ross, Kimberly Mackenzie, Jennifer Stratton, David W Dodick and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Prolactin and pain of endometriosis.Pharmacology & therapeutics · 2023
    Pooled it
  3. Trial
  4. PVNAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. The therapeutic pipeline in migraine: What does the future hold?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. A prolactin-targeting antibody to prevent stress-induced peripheral nociceptor sensitization and female postoperative pain.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Review
  14. Chronification of migraine sensitizes to CGRP in male and female mice.Cephalalgia : an international journal of headache · 2025
    Article
  15. Sexual Dimorphism in Migraine. Focus on Mitochondria.Current pain and headache reports · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Moe WatanabeDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Caroline M KopruszinskiDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Aubin MoutalDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Daigo IkegamiDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Rajesh KhannaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Yanxia ChenDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Sarah RossDepartment of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Kimberly MackenzieTeva Pharmaceutical Industries, Ltd., Biologics Discovery, Redwood City, CA 94063, USA.
Jennifer StrattonTeva Pharmaceutical Industries, Ltd., Biologics Discovery, Redwood City, CA 94063, USA.
David W DodickDepartment of Neurology, Mayo Clinic, Phoenix, AZ 85054, USA.
Edita NavratilovaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.ORCID 0000-0002-1497-125X
Frank PorrecaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
University of Arizona · USMayo Clinic Hospital · USUniversity of Pittsburgh · US

Funding

Investigating the Neural Circuits of ItchR01AR063772 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI H Richard Koerber, Sarah Elizabeth Ross · 2013 to 2026
$6.9M
Molecular genetic dissection of the spinal microcircuits of wind-upR01NS096705 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOERBER, H RICHARD, ROSS, SARAH ELIZABETH · 2016 to 2025
$5.1M
Exploring CRMP5 as a novel target for Alzheimers diseaseR01NS119263 · NINDS · UNIVERSITY OF ARIZONA · PI Aubin Moutal · 2021 to 2026
$2.2M
NIAMS NIH HHS R01 AR063772NINDS NIH HHS R01 NS096705NINDS NIH HHS R01 NS119263
6 · The paper itself

Abstract

Migraine headache results from activation of meningeal nociceptors, however, the hypothalamus is activated many hours before the emergence of pain. How hypothalamic neural mechanisms may influence trigeminal nociceptor function remains unknown. Stress is a common migraine trigger that engages hypothalamic dynorphin/kappa opioid receptor (KOR) signalling and increases circulating prolactin. Prolactin acts at both long and short prolactin receptor isoforms that are expressed in trigeminal afferents. Following downregulation of the prolactin receptor long isoform, prolactin signalling at the prolactin receptor short isoform sensitizes nociceptors selectively in females. We hypothesized that stress may activate the kappa opioid receptor on tuberoinfundibular dopaminergic neurons to increase circulating prolactin leading to female-selective sensitization of trigeminal nociceptors through dysregulation of prolactin receptor isoforms. A mouse two-hit hyperalgesic priming model of migraine was used. Repeated restraint stress promoted vulnerability (i.e. first-hit priming) to a subsequent subthreshold (i.e. second-hit) stimulus from inhalational umbellulone, a TRPA1 agonist. Periorbital cutaneous allodynia served as a surrogate of migraine-like pain. Female and male KORCre; R26lsl-Sun1-GFP mice showed a high percentage of KORCre labelled neurons co-localized in tyrosine hydroxylase-positive cells in the hypothalamic arcuate nucleus. Restraint stress increased circulating prolactin to a greater degree in females. Stress-primed, but not control, mice of both sexes developed periorbital allodynia following inhalational umbellulone. Gi-DREADD activation (i.e. inhibition through Gi-coupled signalling) in KORCre neurons in the arcuate nucleus also increased circulating prolactin and repeated chemogenetic manipulation of these neurons primed mice of both sexes to umbellulone. Clustered regularly interspaced short palindromic repeats-Cas9 deletion of the arcuate nucleus KOR prevented restraint stress-induced prolactin release in female mice and priming from repeated stress episodes in both sexes. Inhibition of circulating prolactin occurred with systemic cabergoline, a dopamine D2 receptor agonist, blocked priming selectively in females. Repeated restraint stress downregulated the prolactin receptor long isoform in the trigeminal ganglia of female mice. Deletion of prolactin receptor in trigeminal ganglia by nasal clustered regularly interspaced short palindromic repeats-Cas9 targeting both prolactin receptor isoforms prevented stress-induced priming in female mice. Stress-induced activation of hypothalamic KOR increases circulating prolactin resulting in trigeminal downregulation of prolactin receptor long and pain responses to a normally innocuous TRPA1 stimulus. These are the first data that provide a mechanistic link between stress-induced hypothalamic activation and the trigeminal nociceptor effectors that produce trigeminal sensitization and migraine-like pain. This sexually dimorphic mechanism may help to explain female prevalence of migraine. KOR antagonists, currently in phase II clinical trials, may be useful as migraine preventives in both sexes, while dopamine agonists and prolactin/ prolactin receptor antibodies may improve therapy for migraine, and other stress-related neurological disorders, in females.

Indexed as

Migraine DisordersNociceptorsAnimalsDopaminergic NeuronsFemaleHyperalgesiaHypothalamusMaleMicePainProlactinReceptors, Opioid, kappaReceptors, ProlactinProlactinReceptors, Opioid, kappaReceptors, Prolactinhypothalamuskappa opioid receptorsmigraineprolactinstress

Identifiers

PMID35325034
PMCPMC9890468
OpenAlexW4220706479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.